SECsense Logo

Guardant Health, Inc. 8-K Report: Key Insights & Developments (Feb 20, 2025)

$GH
Form 8-K
Filed on: 2025-02-20
Source
Guardant Health, Inc. 8-K Report: Key Insights & Developments (Feb 20, 2025)

Based on the provided section of the financial report, here are the key extracted points and insights:

  1. Entity Information:
  • Company Name: Guardant Health, Inc.
  • CIK (Central Index Key): 0001576280
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-38683
  • EIN (Employer Identification Number): 45-4139254
  • Address: 3100 Hanover Street, Palo Alto, CA 94304
  • Contact: 855-698-8887
  1. Report Type:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  1. Filing Date:
  • Date of Report: February 20, 2025
  1. Security Information:
  • Security Type: Common Stock
  • Par Value: $0.00001 per share
  • Trading Symbol: GH
  • Exchange: NASDAQ
  1. Filing Context:
  • The report is structured using XBRL (eXtensible Business Reporting Language), which is a standard for digital business reporting.

Insights:

  • The filing indicates that Guardant Health, Inc. is complying with SEC regulations by submitting an 8-K, which suggests that there may be significant developments worth noting for investors or stakeholders.
  • The date of the report suggests a real-time response to an event or change occurring on the same day as the filing, which is common for 8-K reports.
  • The company operates within the healthcare sector, focusing on innovative technologies, which could be of interest to investors looking for growth opportunities in biotechnology and diagnostics.
  • The low par value of the common stock may indicate an extensive share structure, which is typical for companies in the early stages of growth or those that have undergone stock splits in the past.

This information should be useful for stakeholders analyzing the company's current status and any potential impacts on their investment decisions.